Toxicity testing of oncology drugs: unraveling the last 15 years of progress

Dr. Krishna Allamneni – Concarlo Therapeutics, USA

Watch on HSTalks

Previous
Previous

Is there any power in the policies?

Next
Next

Paving the Way: Bold Perspectives from Female Executives in Biotech featuring Krishna Allamneni